<DOC>
	<DOC>NCT01525823</DOC>
	<brief_summary>The purpose of this study is to assess the effects of Metformin administered over two weeks on the peak plasma glucose concentrations following administration of BMS-754807.</brief_summary>
	<brief_title>Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin</brief_title>
	<detailed_description>Primary Purpose: Other - Protocol designed to evaluate pharmacodynamics following administration of two compounds</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy male and female subjects ages 18 to 55 determined with no clinically significant deviation from normal medical history, physical examination, electrocardiograms (ECGs), and clinical laboratory Women who are not of childbearing potential Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations consistent with a healthy volunteer target population History of clinically relevant hypoglycemic events History of clinically relevant hyperglycemic events</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>